Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The possibility that hypersecretion of corticotropin-releasing factor (CRF) contributes to the hyperactivity of the hypothalamo-pituitary-adrenal axis observed in patients with major depression was investigated by measuring the concentration of this peptide in cerebrospinal fluid of normal healthy volunteers and in drug-free patients with DSM-III diagnoses of major depression, schizophrenia, or dementia. When compared to the controls and the other diagnostic groups, the patients with major depression showed significantly increased cerebrospinal fluid concentrations of CRF-like immunoreactivity; in 11 of the 23 depressed patients this immunoreactivity was greater than the highest value in the normal controls. These findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA alterations correlate with impaired cognitive function 66,67 in depressed patients”
From Major depressive disorder (2016) · cites this paper as [67]
In the citing paper
“elevated basal cerebrospinal fluid CRH levels”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Nemeroff et al., 1984
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citationCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Corticotropin-Releasing Factor: Actions on the Sympathetic Nervous System and Metabolism*
BROWN, M. R., FISHER, L. A., SPIESS, J., RIVIER, C., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-111-3-928 · Cited by 651
Self-citationNeuroendocrine Regulation in Depression: II. Discrimination of Depressed From Nondepressed Patients
Carroll, B. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090041003 · Cited by 627
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 481
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus
Bloom, F. E., Battenberg, E. L. F., Rivier, J., & Vale, W. (1982) · Regulatory Peptides · doi:10.1016/0167-0115(82)90107-0 · Cited by 364
Self-citationGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Research works printed but not linked: 6
- Carroll, B. J., Handbook on Depression: 325 (1977).
- FISHMAN, A.J., PEPTIDES 1: 149 (1982).
- Rivier, J., Proceedings of the National Academy of Sciences of the United States of America 80: 4851 (1983).
- SNEDECOR, G.W., STAT METHODS: 271 (1967).
- SOKAL, R.R., BIOMETRY: 391 (1969).
- WHYBROW, P.C., MOOD DISORDERS NEW P: 1 (1984).
Cited by
Items 701–800 of 1,001
Horstmann, S., Dose, T., Lucae, S., Kloiber, S., Menke, A., Hennings, J., Spieler, D., Uhr, M., Holsboer, F., & Ising, M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.004 · Cited by 44
“The number of CRH secreting neurons in the PVN and frontal regions are increased (Raadsheer et al., 1994) with consecutively elevated CRH-levels in the CSF (Nemeroff et al., 1984).”
BackgroundLee, R. J., Gollan, J., Kasckow, J., Geracioti, T., & Coccaro, E. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301104 · Cited by 44
Weathington, J. M., Arnold, A. R., & Cooke, B. M. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.10.008 · Cited by 50
“…stress-related mood disorders is hypothalamic–pituitary–adrenal (HPA) axis dysregulation, evident in resistance to dexamethasone-induced suppression of cortisol release (Nemeroff and Evans, 1984), and in elevated cerebrospinal fluid levels of corticotrophin releasing factor (Nemeroff et al., 1984).”
New directions in the development of antidepressants: the interface of neurobiology and psychiatry
Nemeroff, C. B. (2002) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.396 · Cited by 45
“…fluid (CSF) concentrations of CRF in untreated depressed patients and suicide victims, but not in patients with other psychiatric disorders or in healthy volunteers (Arató et al., 1986; Arató et al., 1989; Bánki et al., 1987; Bánki et al., 1992a; France et al., 1988; Nemeroff et al., 1984).”
BackgroundResultSelf-citationHypothalamic-Pituitary-Adrenal Axis Function in Elderly Endurance Athletes
HEUSER, I. J. E., WARK, H.-J., KEUL, J., & HOLSBOER, F. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-3-485 · Cited by 42
Leake, A., Perry, E. K., Perry, R. H., FAIRBAIRN, A. F., & Ferrier, I. N. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90398-l · Cited by 44
WILLIAMS, E. S., Mazei‐Robison, M. S., & Robison, A. J. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a039198 · Cited by 44
By what molecular mechanisms do social determinants impact cardiometabolic risk?
Baumer, Y., Pita, M. A., Baez, A. S., Ortiz-Whittingham, L. R., Cintron, M., Rose, R., Gray, V. C., Baah, F. O., & Powell‐Wiley, T. M. (2023) · Clinical Science · doi:10.1042/cs20220304 · Cited by 45
Liu, Z., Liu, W., Yao, L., Yang, C., Xiao, L., Wan, Q., Gao, K., Wang, H., Zhu, F., Wang, G., et al. (2013) · Scientific Reports · doi:10.1038/srep01548 · Cited by 39
Farkas, J. I., Kovács, L. Á., Gáspár, L., Nafz, A. E., Gaszner, T., Ujvari, B., Kormos, V., CSERNUS, V. J., Hashimoto, H., Reglődi, D., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.019 · Cited by 45
Qin, X., Shan, Q., Fang, H., Wang, Y., Chen, P., Xiong, Z., Swaab, D. F., & Zhou, J. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02371-7 · Cited by 44
Heteroatom-linked indanylpyrazines are corticotropin releasing factor type-1 receptor antagonists
Corbett, J. W., Rauckhorst, M. R., Qian, F., Hoffman, R. L., Knauer, C. S., & Fitzgerald, L. W. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.008 · Cited by 45
Emoto, H., Koga, C., Ishii, H., Yokoo, H., Yoshida, M., & Tanaka, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90762-c · Cited by 43
Inflammatory markers and suicidal attempts in depressed patients: A review
Marini, S., Vellante, F., Matarazzo, I., De Berardis, D., Serroni, N., Gianfelice, D., Olivieri, L., Di Renzo, F., Di Marco, A., Fornaro, M., et al. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015623793 · Cited by 42
Kratzer, S., Mattusch, C., Metzger, M. W., Dedic, N., Noll‐Hussong, M., Kafitz, K. W., Eder, M., Deussing, J. M., Holsboer, F., Kochs, E. F., et al. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00091 · Cited by 45
“Increased concentrations of CRH were found in the cerebrospinal fluid (CSF) of a subset of patients with depression (Nemeroff et al., 1984; Holsboer, 2000) and also a number of endocrine function tests (Holsboer, 2000) were in agreement with elevations of central CRH in many severely depressed…”
BackgroundResultInfluentialChen, Y., Holzman, C., Chung, H., Senagore, P., Talge, N. M., & Siler-Khodr, T. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.11.007 · Cited by 41
Stiedl, O., Meyer, M., Jahn, O., Ögren, S. O., & Spiess, J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075820 · Cited by 42
Depression in Patients With Heart Failure: Physiologic Effects, Incidence, and Relation to Mortality
Thomas, S. A., Friedmann, E., Khatta, M., Cook, L. K., & Lann, A. L. (2003) · AACN Clinical Issues Advanced Practice in Acute & Critical Care · doi:10.1097/00044067-200302000-00002 · Cited by 49
The Hypothalamic–Pituitary–Adrenocortical Axis in Major Depression
Stokes, P. E., & Sikes, C. R. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30430-4 · Cited by 44
NEUROENDOCRINE FUNCTION IN OBESITY
Kopelman, P. G. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03860.x · Cited by 43
Bone density measurement in major depression
D. Amsterdam, J., & Hooper, M. B. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00003-7 · Cited by 41
Chan, H., Chang, C., Chiang, S. C., Chen, J., Chen, C., Sun, H., Hwu, H., & Lai, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108096070 · Cited by 42
File, S. E. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90024-v · Cited by 45
Heisler, L. E., Pallotta, C. M., Reid, R. L., & Vugt, D. A. V. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.5.8388404 · Cited by 43
Morley, J. E., Silver, A. J., Miller, D. K., & Rubenstein, L. Z. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb53231.x · Cited by 41
Fife, M. S., Fisher, S. A., John, S., Worthington, J., Shah, C., Ollier, W., Panayi, G. S., Lewis, C. M., & Lanchbury, J. S. S. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1673::aid-anr2>3.0.co;2-y · Cited by 43
Aubry, J.-M. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2013.09.003 · Cited by 40
Sex-biased cellular signaling: molecular basis for sex differences in neuropsychiatric diseases
Valentino, R. J., & Bangasser, D. A. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/rvalentino · Cited by 40
Recent Findings in the Pathophysiology of Depression
Nemeroff, C. B. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.1.foc3 · Cited by 49
Self-citationDisorders of Eating in the Elderly
Berry, E. M., & Marcus, E. (2000) · Journal of Adult Development · doi:10.1023/a:1009575706990 · Cited by 40
“Nelson and Farberow (1982) reported finding, over a 1-week follow-up period, some form of ISDB in 88% of men (mean age 70 years) who were hospitalized with a chronic medical condition for one week in an intermediate care geriatric unit.”
BackgroundAberrant REST-mediated transcriptional regulation in major depressive disorder
Otsuki, K., Uchida, S., Wakabayashi, Y., Matsubara, T., Hobara, T., Funato, H., & Watanabe, Y. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.09.009 · Cited by 40
Conti, L. H., & Foote, S. L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00175-8 · Cited by 40
Spiegel, D. (2001) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(00)00200-2 · Cited by 49
The Locus Coeruleus: Anatomy, Physiology, and Stress‐Related Neuropsychiatric Disorders
Reyes, B. A. S. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70111 · Cited by 42
“This cascade of events could lead to stress-related neuropsychiatric disorders (Nemeroff et al. 1984; Lesch et al. 1988; Bremner et al. 1997).”
Michopoulos, V., Berga, S. L., & Wilson, M. E. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0025008 · Cited by 40
“, 1999), are linked to the dysregulation of the stress axis associated with exposure to chronic stressors in rodents (Lopez, Chalmers, Little, & Watson, 1998) and stressful life events in humans (Nemeroff et al., 1984).”
BackgroundSchulkin, J. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/jschulkin · Cited by 39
Bijlsma, E. Y., van Leeuwen, M. L. F., Westphal, K. G. C., Olivier, B., & Groenink, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.026 · Cited by 45
Dedic, N., Touma, C., Romanowski, C. P. N., Schieven, M., Kühne, C., Ableitner, M., Lu, A., Holsboer, F., Wurst, W., Kimura, M., et al. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9784-0 · Cited by 43
Nishino, S., Mignot, E., Benson, K. L., & Zarcone, Jr. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00012-2 · Cited by 39
Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders
Chaki, S., Okubo, T., & Sekiguchi, Y. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906775245318 · Cited by 39
Are CRF receptor antagonists potential antidepressants?
O'Brien, D., Skelton, K. H., Owens, M. J., & Nemeroff, C. B. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.187 · Cited by 45
Self-citationKrolewski, D. M., Medina, A. M., Kerman, I. A., Bernard, R., Burke, S., Thompson, R. C., Bunney, W. E., Schatzberg, A. F., Myers, R., Akil, H., et al. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22480 · Cited by 40
“Studies of the functional and anatomical relationships between hypothalamic nuclei, which collectively produce no fewer than 20 different neuropeptides to regulate such processes (Palkovits, 1984), have relied heavily on the use of rodents.”
BackgroundSchulkin, J. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610349 · Cited by 38
“Consistent with this, CRH is elevated in the cerebrospinal fluid, together with elevated systemic levels of cortisol, in people who are chronically fearful/anxious and depressed (Nemeroff et al. 1984, Gold et al. 1988, Kling et al. 1993, Nemeroff 1992).”
Cerebrospinal Fluid Correlates of Depression in Huntington's Disease
Kurlan, R., Caine, E. D., Rubin, A., Nemeroff, C. B., Bissette, G., Zaczek, R. C., Coyle, J. J., Spielman, F. J., Irvine, C., & Shoulson, I. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520320071018 · Cited by 41
Self-citationHsin, L., Tian, X., WEBSTER, E. L., Coop, A., Caldwell, T. M., Jacobson, A. E., Chrousos, G. P., Gold, P. W., Habib, K. E., Ayala, A. R., et al. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00261-9 · Cited by 40
Dietary tyrosine suppresses the rise in plasma corticosterone following acute stress in rats
Reinstein, D. K., Lehnert, H., & Wurtman, R. J. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90566-1 · Cited by 38
Grossmann, C., & Roselle, G. A. (1986) · Progress in clinical biochemistry and medicine · doi:10.1007/978-3-642-71502-0_1 · Cited by 38
Ohmura, Y., Yamaguchi, T., Futami, Y., Togashi, H., Izumi, T., Matsumoto, M., Yoshida, T., & Yoshioka, M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.025 · Cited by 37
Sekita, A., Arima, H., Ninomiya, T., Ohara, T., Doi, Y., Hirakawa, Y., Fukuhara, M., Hata, J., Yonemoto, K., Ga, Y., et al. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-862 · Cited by 39
“One of the mechanisms underlying the association between MetS and depressive symptoms is thought to be the stress-induced hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, which is common in depression [30-32] and could lead to metabolic alterations [33-35].”
BackgroundCorticotropin-releasing factor-binding protein, stress and major depression
Eede, F. V. D., Broeckhoven, C. V., & Claes, S. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.02.002 · Cited by 41
Bruijnzeel, A. W., Small, E., Pasek, T. M., & Yamada, H. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.043 · Cited by 37
“This is supported by the observation that CRF levels are elevated in patients with depression and CRF levels decrease upon successful treatment with antidepressants [7,20].”
BackgroundNeuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression
Paschos, K. A., Veletza, S. V., & Chatzaki, Ε. (2009) · CNS Drugs · doi:10.2165/11310830-000000000-00000 · Cited by 43
“Post-mortem studies reveal that CRF receptor levels are suppressed in the prefrontal cortex of individuals who committed suicide.([140-143]) Furthermore, preclinical data in laboratory models indicate that CRF administration in the brain of laboratory animals reproduces symptoms of MDD, including loss of appetite, ins…”
BackgroundLinthorst, A. C. E. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_7 · Cited by 39
Garza, R. D. L., Asnis, G. M., Fabrizio, K., & Pedrosa, E. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2053-x · Cited by 38
“A close linkage between flu-like syndrome and major depressive disorder (MDD) in humans has been predicted to arise due to hypersecretion of pro-inflammatory cytokines (Licinio and Wong 1999; Maes 1999; Anisman and Merali 2002; Irwin 2002), and/or chronic activation of the hypothalamic pituitary adrenal (HPA) axis (Ne…”
BackgroundCOPLAN, J. D., SMITH, E. L. P., ALTEMUS, M., MATHEW, S. J., PERERA, T., KRAL, J. G., GORMAN, J. M., OWENS, M. J., NEMEROFF, C. B., & ROSENBLUM, L. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.057 · Cited by 37
Self-citationRupprecht, R., Kornhuber, J., Wodarz, N., Lugauer, J., Göbel, C., Haack, D., Beck, G., Müller, O. A., Riederer, P. F., & Beckmann, H. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90252-h · Cited by 40
Prenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex
Szymańska, M., Beroun, A., Budziszewska, B., Jaworska-Feil, L., Basta‐Kaim, A., Leśkiewicz, M., Kubera, M., Gergont, A., Kroczka, S., Kaciński, M., et al. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70113-6 · Cited by 37
“In fact, stress is regarded as a risk factor for depression, and a large number of depressed patients exhibit hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis [16, 22].”
Depression in Diabetic Retinopathy: A Review and Recommendation for Psychiatric Management
Chen, X. N., & Lü, L. (2016) · Psychosomatics · doi:10.1016/j.psym.2016.04.003 · Cited by 38
Psychiatric Disorders - Trends and Developments
(2011) · InTech eBooks · doi:10.5772/2330 · Cited by 35
Mall, J. G., Löfvendahl, L., Lindqvist, C. M., Brummer, R. J., Keita, Å. V., & Schoultz, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-31492-5 · Cited by 39
Takahashi, Y., Hibi, S., Hoshino, Y., Kikuchi, K., Shin, K., Murata-Tai, K., Fujisawa, M., Ino, M., Shibata, H., & Yonaga, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300259r · Cited by 36
Busnardo, C., Crestani, C. C., Scopinho, A. A., Packard, B. A., Resstel, L. B. M., Corrêa, F. M. D. A., & Herman, J. P. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.001 · Cited by 36
CRH Effects on Central Noradrenergic Neurons: Relationship to Stress
Valentino, R. J. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-2064-5_5 · Cited by 39
Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression
Baghai, T. C., Schüle, C., Zwanzger, P., Minov, C., Holme, C., Padberg, F., Bidlingmaier, M., Strasburger, C. J., & Rupprecht, R. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00060-9 · Cited by 38
“, 1987) and elevated levels of corticotropin releasing hormone (CRH) in the cerebrospinal fluid (CSF) (Nemeroff et al., 1984).”
BackgroundBuwalda, B., Kalkeren, A. A. V., de Boer, S. F., & Koolhaas, J. M. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00096-6 · Cited by 39
“Clinical studies have found direct and indirect evidence supporting the hypothesis that CRF is hypersecreted from one or more populations of neurons in the brain of patients diagnosed for major depressive disorder, as indicated by the increased concentrations of CRF in the cerebrospinal fluid of these patients (Nemero…”
BackgroundInfluentialPre- and post-dexamethasone plasma ACTH levels in depressed patients and normal controls
Roy, A., Gold, P. W., Pickar, D., Wolkowitz, O. M., Chrousos, G. P., & Paul, S. M. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90032-7 · Cited by 38
Molchan, S. E., Hill, J., Mellow, A. M., LAWLOR, B. A., Martínez, R. A., & Sunderland, T. (1990) · International Psychogeriatrics · doi:10.1017/s1041610290000370 · Cited by 37
Al Shweiki, M. R., Oeckl, P., Steinacker, P., Hengerer, B., Schönfeldt-Lecuona, C., & Otto, M. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1336435 · Cited by 33
“immunoreactivity in drug-free MDD patients [115,116].”
Pandey, G. N., Rizavi, H. S., Bhaumik, R., & Ren, X. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.04.015 · Cited by 35
“(1984) found elevated CSF CRF levels in depressed patients, most of them were DST nonsuppressors (Nemeroff et al., 1984).”
BackgroundHistone modifications of the Crhr1 gene in a rat model of depression following chronic stress
Wan, Q., Gao, K., Rong, H., Wu, M., Wang, H., Wang, X., Wang, G., & Liu, Z. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.031 · Cited by 36
The relevance of feedforward loops
Cools, A. R. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0004752x · Cited by 35
Neuroendocrine markers of stress.
Hargreaves, K. (1990) · PubMed · Cited by 41
Herr, A. S., Tsolakidou, A. F., Yassouridis, A., Holsboer, F., & Rein, T. (2003) · Neuroendocrinology · doi:10.1159/000071701 · Cited by 34
“These findings can be linked to hypersecretion of corticotropin-releasing hormone (CRH) in the hypothalamus [”
BackgroundDelayed effects of stress and immune activation
Tilders, F. J. H., Schmidt, E. D., Hoogedijk, W. J. G., & Swaab, D. F. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0040 · Cited by 36
Hartz, R. A., Ahuja, V. T., Arvanitis, A. G., Rafalski, M., Yue, E. W., Denhart, D. J., Schmitz, W. D., Ditta, J. L., Deskus, J. A., Brenner, A. B., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900301y · Cited by 36
Association of comorbid depression with inpatient outcomes in critical limb ischemia
Zahner, G. J., Cortez, A., Duralde, E. R., Ramirez, J. L., Wang, S., Hiramoto, J. S., Cohen, B. E., Wolkowitz, O. M., Arya, S., Hills, N. K., et al. (2019) · Vascular Medicine · doi:10.1177/1358863x19880277 · Cited by 36
Rømer, T. B., Jeppesen, R., Christensen, R. H. B., & Benros, M. E. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02059-2 · Cited by 35
Effects of Maternal Stress on Development and Behaviour in Rat Offspring
Weinstock, M. (2001) · Stress · doi:10.3109/10253890109035015 · Cited by 32
“, 1994) and of CRF in the cerebroventricular fluid (Nemeroff et al., 1984).”
BackgroundThe Role of the HPA Axis in Psychiatric Disorders and CRF Antagonists as Potential Treatments
Keller, P. A., McCluskey, A., Morgan, J., & O'Connor, S. M. J. (2006) · Archiv der Pharmazie · doi:10.1002/ardp.200600021 · Cited by 40
Corticotropin Releasing Hormone: a Diagnostic Marker for Behavioral and Reproductive Disorders?
Florio, P., Zatelli, M. C., Reis, F. M., Uberti, E. C. D., & Petraglia, F. (2006) · Frontiers in bioscience · doi:10.2741/2081 · Cited by 38
“Roy A, D. Pickar, S. Paul, A. Doran, G.P. Chrousos & P.W. Gold: CSF corticotropin-releasing hormone in depressed patients and normal control subjects.”
BackgroundInfluentialCardiovascular Health and Depression
Glassman, A. H., Shapiro, P. A., Ford, D. E., Culpepper, L., Finkel, M. S., Swenson, J. R., Bigger, J. T., Rollman, B. L., & Wise, T. N. (2003) · Journal of Psychiatric Practice · doi:10.1097/00131746-200311000-00004 · Cited by 35
Conti, L. H., & Foote, S. L. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00222-5 · Cited by 36
Nishikawa, H., Hata, T., Itoh, E., & Funakami, Y. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.352 · Cited by 42
Relation between psychological strain and carotid atherosclerosis in a general population
Wolff, B., Grabe, H. J., Völzke, H., Lüdemann, J., Kessler, C., Dahm, J. B., Freyberger, H. J., John, U., & Felix, S. B. (2005) · Heart · doi:10.1136/hrt.2003.031088 · Cited by 36
In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001
Chaki, S., Okuyama, S., Nakazato, A., Kumagai, T., Okubo, T., Ikeda, Y., Oshida, Y., Hamajima, Y., & Tomisawa, K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00120-x · Cited by 36
The Hypothalamic-Pituitary-Adrenal Axis in Depression
Julio‐Pieper, M., & Dinan, T. G. (2010) · Modern trends in psychiatry · doi:10.1159/000319427 · Cited by 36
Neuroendocrine responses to social stress
Herbert, J. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80072-1 · Cited by 36
Diazepam‐binding inhibitor and corticotropin‐releasing hormone in cerebrospinal fluid
Roy, A., Pickar, D., Gold, P. W., Barbaccia, M. L., Guidotti, A., Costa, E., & Linnoila, M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01339.x · Cited by 38
“Cerebrospinal fluid (CSF) levels of CRH have been reported to be elevated in depression (15, 16), and we (17) have reported a significant positive correlation between CSF levels of CRH and postdexamethasone plasma levels of cortisol in depressed patients.”
BackgroundSearching for a technology of behavior
Kolb, B. E., Jacobs, W. J., & Petrie, B. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047610 · Cited by 35
Cognitive correlates of hypothalamic–pituitary–adrenal axis in major depression
Schlosser, N., Wolf, O. T., & Wingenfeld, K. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.79 · Cited by 33
Larrieu, T., Hilal, M. L., Smedt, V. D., Sans, N., & Layé, S. (2015) · Neural Plasticity · doi:10.1155/2016/8574830 · Cited by 37
Hughes, F. M., Odom, M. R., Cervantes, A., Livingston, A. J., & Purves, J. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032821 · Cited by 34
“The second major correlate of MDD is dysregulation of the HPA axis which disrupts the negative feedback and leads to hypersecretion of glucocorticoids [60].”
BackgroundInvolvement of Neuropeptide Systems in Schizophrenia: Human Studies
Cáceda, R., Kinkead, B. L., & Nemeroff, C. B. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78011-4 · Cited by 39
Self-citationN-3 (Omega-3) Fatty Acids in Postpartum Depression: Implications for Prevention and Treatment
Levant, B. (2010) · Depression Research and Treatment · doi:10.1155/2011/467349 · Cited by 47
“These findings include elevated basal levels of serum cortisol, increased corticotrophin-releasing factor in cerebral spinal fluid [136–138], and disruption of negative feedback mechanisms [139].”
BackgroundEffects of personality traits on the manifestations of irritable bowel syndrome
Tayama, J., Nakaya, N., Hamaguchi, T., Tomiie, T., Shinozaki, M., Saigo, T., Shirabe, S., & Fukudo, S. (2012) · BioPsychoSocial Medicine · doi:10.1186/1751-0759-6-20 · Cited by 37
“In patients with depression, the hypothalamic-pituitary-adrenocortical (HPA) axis is reported to be activated [35-37].”
BackgroundMicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression
Aschrafi, A., Verheijen, J. M., Gordebeke, P. M., Olde Loohuis, N. F., Menting, K., Jager, A., Palkovits, M., Geenen, B., Kos, A., Martens, G. J. M., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150154 · Cited by 31
The Animal–Human Bond: Health and Wellness
Friedmann, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22346-4.00015-9 · Cited by 36
Stress system alterations and mood disorders in suicidal patients. A review
Westrin, Å. (2000) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(00)89047-2 · Cited by 36
Effects of psychologic stress on fetal development and pregnancy outcome
Koubovec, D., Geerts, L., Odendaal, H. J., Stein, D. J., & Vythilingum, B. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0081-9 · Cited by 39
Vécsei, L., & Widerlöv, E. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06401.x · Cited by 33
Self-citation
Metadata
- Authors
- Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W.
- Affiliations
- Duke University (US)
- Uppsala University (SE)
- Duke Medical Center (US)
- University of Gothenburg (SE)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1984-12-14
- Volume
- 226
- Issue
- 4680
- Pages
- 1342-1344
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1974253960
- Semantic Scholar
- 1a0f9dda77d66396db9247777d53158b0628b325
- Cited by
- 1,485
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 34 · 2016: 36 · 2015: 34 · 2014: 46 · 2013: 39 · 2012: 37
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, cerebrospinal fluid, major depressive disorder, hypothalamic-pituitary-adrenal axis, hypersecretion, schizophrenia, dementia
- MeSH terms
- Adult, Aged, Corticotropin-Releasing Hormone, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Radioimmunoassay, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.